GPhA: Generics saved US $217bn in 2012, $1.2tn over 10 years
This article was originally published in Scrip
Executive Summary
The US healthcare system saved $217bn in 2012 by selecting generic medicines over their innovators, the Generic Pharmaceutical Association (GPhA) said in a new analysis, insisting the savings over a decade have amounted to as much as $1.2tn.